Skip to main content
NIH funding notice PAR-20-062

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

Closed on January 7, 2023.

Posted
November 22, 2019
Close date
January 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,368,790 in first-year total cost, median $684,395.

Most frequent study sections

  1. Digestive System Host Defense, Microbial Interactions and Immune and Inflammatory Disease Study Section[DHMI]1
  2. Immunity and Host Defense Study Section[IHD]1

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  2. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under PAR-20-062 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis1R01CA281732-01FOX, JAMES GPEEK, RICHARD M.VANDERBILT UNIVERSITY MEDICAL CENTER, TN$699,695DHMI
2022Discovering Infection-mediated Pathways of Glioma Etiology and Prognosis by Leveraging Multiplex Serology and Immunogenomics1R01CA266676-01A1FRANCIS, STEPHEN STARKOUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$669,095IHD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-062: Co-infection and Cancer (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience